Immunocytological Detection of Lymph Node Metastases in Dogs with Malignant Epithelial Tumours

Journal of Comparative Pathology

Volumn 137, Issue 1, 2007, Pages 1-8

  Hoinghaus R ^a   von Wasielewski, R ^b   Hewicker Trautwein, M ^a   Freund, M ^c   Mischke, R ^d  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d NONE

Author keywords

dog; lymph node metastases; metastasis detection; tumour prognosis

Indexed keywords

CYTOKERATIN ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASPIRATION BIOPSY; CARCINOMA; CONTROLLED STUDY; CROSS REACTION; CYTOLOGY; DOG; EPITHELIUM CELL; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MICROMETASTASIS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANIMALS; ANTIBODIES; BIOPSY, FINE-NEEDLE; CARCINOMA; CYTODIAGNOSIS; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; LYMPH NODES; LYMPHATIC METASTASIS; SENSITIVITY AND SPECIFICITY;

CANIS FAMILIARIS;

EID: 34447129760     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2007.02.004     Document Type: Article

References (31)

1. Aihara T., Munakata S., Morino H., and Takatsuka Y. Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Annals of Surgical Oncology 11 (2004) 747-750
2. Busch U., and Rudolph R. Mammakarzinom der Hündin: eine neue Routinediagnostik zum Nachweis okkulter Mikrometastasen in den regionären Lymphknoten. Berliner und Münchener Tierärztliche Wochenschrift 108 (1995) 43-46
3. Cohen C., Alazraki N., Styblo T., Waldrop S.M., Grant S.F., and Larsen T. Immunohistochemical evaluation of sentinel lymph nodes in breast carcinoma patients. Applied Immunohistochemistry and Molecular Morphology 10 (2002) 296-303
4. Cserni G. Axillary staging of breast cancer and the sentinel node. Journal of Clinical Pathology 53 (2000) 733-741
5. Czerniecki B.J., Scheff A.M., Callans L.S., Spitz F.R., Bedrosian I., Conant E.F., Orel S.G., Berlin J., Helsabeck C., Fraker D.L., and Reynolds C. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85 (1999) 1098-1103
6. Doki Y., Ishikawa O., Mano M., Hiratsuka M., Sasaki Y., Kameyama M., Ohigashi H., Murata K., Yamada T., Miyashiro I., Yokoyama S., Ishiguro S., and Imaoka S. Cytokeratin deposits in lymph nodes show distinct clinical significance from lymph node micrometastasis in human esophageal cancers. Journal of Surgical Research 107 (2002) 75-81
7. Domagala W., Bedner E., Chosia M., Weber K., and Osborn M. Keratin-positive reticulum cells in fine needle aspirates and touch imprints of hyperplastic lymph nodes. A possible pitfall in the immunocytochemical diagnosis of metastatic carcinoma. Acta Cytologica 36 (1992) 241-245
8. Hartveit F., and Lilleng P.K. Breast cancer: two micrometastatic variants in the axilla that differ in prognosis. Histopathology 28 (1996) 241-246
9. Jiang J., Ulbright T.M., Younger C., Sanchez K., Bostwick D.G., Koch M.O., Eble J.N., and Cheng L. Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Archives of Pathology and Laboratory Medicine 125 (2001) 921-923
10. Lee E., Chae Y., Kim I., Choi J., Yeom B., and Leong A.S. Prognostic relevance of immunohistochemically detected lymph node metastasis in patients with gastric carcinoma. Cancer 94 (2002) 2867-2873
11. Linden M.D., and Zarbo R.J. Cytokeratin immunostaining patterns of benign, reactive lymph nodes: applications for the evaluation of sentinel lymph node specimens. Applied Immunohistochemistry and Molecular Morphology 9 (2001) 297-301
12. Liu L.H., Siziopikou K.P., Gabram S., and McClathy K.D. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma. Archives of Pathology and Laboratory Medicine 124 (2000) 1670-1673
13. Löffler H., and Rastetter J. Atlas of Clinical Haematology (1979), Springer, Berlin, Heidelberg
14. Mischke R. Lymphknotenzytologie in der Kleintierpraxis: 1. Indikation, Probengewinnung und Präparateherstellung. Der Praktische Tierarzt 86 (2005) 86-93
15. Moll R. Cytokeratine als Differenzierungsmarker. Expressionsprofile von Epithelien and epithelialen Tumoren (1993), Gustav Fischer Verlag, Stuttgart, Jena, New York
16. Moll R., Franke W.W., Schiller D.L., Geiger B., and Krepler R. The catalogue of human cytokeratins. Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 (1982) 11-24
17. Moll R., Löwe A., Laufer J., and Franke W.W. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. American Journal of Pathology 140 (1992) 427-447
18. Munakata S., Aihara T., Morino H., and Takatsuka Y. Application of immunofluorescence for intraoperative evaluation of sentinel lymph nodes in patients with breast carcinoma. Cancer 98 (2003) 1562-1568
19. Nakanishi Y., Ochiai A., Yamauchi Y., Moriya Y., Yoshimura K., and Hirohashi S. Clinical implications of lymph node micrometastases in patients with colorectal cancers. Oncology 57 (1999) 276-280
20. Noel P., Tabone E., Michot J.P., Groleas M., Hesch M., and Rifki A.M. Detection of micrometastases in excised regional lymph nodes in cancer of the breast. Systematic use of KL1 anticytokeratin monoclonal antibodies in a prospective series of 120 T2 N-patients. Annales de Pathologie 9 (1989) 265-270
21. Pendas S., Dauway E., Cox C.E., Giuliano R., Ku N.N., Schreiber R.H., and Reintgen D.S. Sentinel lymph node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. American Surgeon 65 (1999) 500-505
22. Ramaekers F.C.S., Huysmans A., Schaart G., Moeseker O., and Vooijs P. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Experimental Cell Research 170 (1987) 235-249
23. Ramaekers F., Van Niekerk C., Poels L., Schaafsma E., Huijsmans A., Robben H., Schaart G., and Vooijs P. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinoma. American Journal of Pathology 136 (1990) 641-655
24. Salem A.A., Douglas-Jones A.G., Sweetland H.M., Newcombe R.G., and Mansel R.E. Evaluation of axillary lymph nodes using touch imprint cytology and immunohistochemistry. British Journal of Surgery 89 (2002) 1386-1389
25. Sobin L.H., and Wittekind C. TNM Classification of Malignant Tumors (2002), Wiley, Ontario, Canada
26. Tajima Y., Tomioka T., Ikematsu Y., Ichinose K., Inque K., and Kanematsu T. Immunohistochemical demonstration of cytokeratin is useful for detecting micrometastatic foci from gallbladder carcinoma in regional lymph nodes. Japanese Journal of Clinical Oncology 29 (1999) 425-428
27. Tseng S.C.G., Jarvinen M.J., Nelson W.G., Huang J.W., Woodcock-Mitchell J., and Sun T.T. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell 30 (1982) 361-372
28. Turner R.R., Giuliano A.E., Hoon D.S.B., Glass E.C., and Krasne D.L. Pathologic examination of sentinel lymph node for breast carcinoma. World Journal of Surgery 25 (2001) 798-805
29. Viac J., Reano A., Brochier J., Staquet M.J., and Thivolet J. Reactivity pattern of monoclonal antikeratin antibody (KL1). Journal of Investigative Dermatology 81 (1983) 351-354
30. Viale G., Bosari S., Mazzarol G., Galimberti V., Luini A., Veronesi P., Paganelli G., Bedoni M., and Orvieto E. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85 (1999) 2433-2438
31. Wong S.L., Chao C., Edwards M.J., Simpson D., and McMaster K.M. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. American Journal of Surgery 182 (2001) 330-334